Cargando…

Differential prioritization of therapies to subtypes of triple negative breast cancer using a systems medicine method

Triple negative breast cancer (TNBC) is a group of cancers whose heterogeneity and shortage of effective drug therapies has prompted efforts to divide these cancers into molecular subtypes. Our computational platform, entitled GenEx-TNBC, applies concepts in systems biology and polypharmacology to p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wathieu, Henri, Issa, Naiem T., Fernandez, Aileen I., Mohandoss, Manisha, Tiek, Deanna M., Franke, Jennifer L., Byers, Stephen W., Riggins, Rebecca B., Dakshanamurthy, Sivanesan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5696233/ https://www.ncbi.nlm.nih.gov/pubmed/29190967 http://dx.doi.org/10.18632/oncotarget.21669

Ejemplares similares

DrugGenEx-Net: a novel computational platform for systems pharmacology and gene expression-based drug repurposing
por: Issa, Naiem T., et al.
Publicado: (2016)

ES-Screen: A Novel Electrostatics-Driven Method for Drug Discovery Virtual Screening
por: Issa, Naiem T., et al.
Publicado: (2022)

A novel chemo-phenotypic method identifies mixtures of salpn, vitamin D3, and pesticides involved in the development of colorectal and pancreatic cancer
por: Issa, Naiem T., et al.
Publicado: (2022)

Estrogen-related receptor β (ERRβ) – renaissance receptor or receptor renaissance?
por: Divekar, Shailaja D., et al.
Publicado: (2016)

Retinoic Acid Mediates Regulation of Network Formation by COUP-TFII and VE-Cadherin Expression by TGFβ Receptor Kinase in Breast Cancer Cells
por: Prahalad, Priya, et al.
Publicado: (2010)

IntegralVac: A Machine Learning-Based Comprehensive Multivalent Epitope Vaccine Design Method
por: Suri, Sadhana, et al.
Publicado: (2022)

A New Hybrid Neural Network Deep Learning Method for Protein–Ligand Binding Affinity Prediction and De Novo Drug Design
por: Limbu, Sarita, et al.
Publicado: (2022)

Predicting Chemical Carcinogens Using a Hybrid Neural Network Deep Learning Method
por: Limbu, Sarita, et al.
Publicado: (2022)

Predicting Dose-Dependent Carcinogenicity of Chemical Mixtures Using a Novel Hybrid Neural Network Framework and Mathematical Approach
por: Limbu, Sarita, et al.
Publicado: (2023)

G-CODE: enabling systems medicine through innovative informatics
por: Madhavan, Subha, et al.
Publicado: (2011)

Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer
por: Heckler, Mary M., et al.
Publicado: (2016)

A New Epitope Selection Method: Application to Design a Multi-Valent Epitope Vaccine Targeting HRAS Oncogene in Squamous Cell Carcinoma
por: Savsani, Kush, et al.
Publicado: (2021)

Single-Cell and Bulk RNASeq Profiling of COVID-19 Patients Reveal Immune and Inflammatory Mechanisms of Infection-Induced Organ Damage
por: Bass, Alexandrea, et al.
Publicado: (2021)

Predicting Dose-Range Chemical Toxicity using Novel Hybrid Deep Machine-Learning Method
por: Limbu, Sarita, et al.
Publicado: (2022)

SARS-CoV-2 Omicron (BA.1 and BA.2) specific novel CD8+ and CD4+ T cell epitopes targeting spike protein
por: Parn, Simone, et al.
Publicado: (2022)

A Peptide Vaccine Design Targeting KIT Mutations in Acute Myeloid Leukemia
por: Kim, Minji, et al.
Publicado: (2023)

“Teaching old drugs to kill new bugs”: structure-based discovery of anti-SARS drugs
por: Rajnarayanan, Rajendram V., et al.
Publicado: (2004)

Host targeted antiviral (HTA): functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation
por: Ullah, Hemayet, et al.
Publicado: (2019)

Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism
por: Policard, Martine, et al.
Publicado: (2021)

Immune characterization and profiles of SARS-CoV-2 infected patients reveals potential host therapeutic targets and SARS-CoV-2 oncogenesis mechanism
por: Policard, Martine, et al.
Publicado: (2021)

TNBCtype: A Subtyping Tool for Triple-Negative Breast Cancer
por: Chen, Xi, et al.
Publicado: (2012)

Subtyping Of Triple Negative Breast Carcinoma On The Basis Of RTK Expression
por: Hessel, Harald, et al.
Publicado: (2018)

Triple-negative breast cancer molecular subtyping and treatment progress
por: Yin, Li, et al.
Publicado: (2020)

Molecular stratification within triple-negative breast cancer subtypes
por: Wang, Dong-Yu, et al.
Publicado: (2019)

Molecular subtypes and precision treatment of triple-negative breast cancer
por: Zhao, Shen, et al.
Publicado: (2020)

Reassessment of Reliability and Reproducibility for Triple-Negative Breast Cancer Subtyping
por: Yu, Xinjian, et al.
Publicado: (2022)

DNA damage and metabolic mechanisms of cancer drug resistance
por: Tiek, Deanna, et al.
Publicado: (2022)

Optical Redox Imaging Differentiates Triple-Negative Breast Cancer Subtypes
por: Jiang, Jinxia, et al.
Publicado: (2021)

Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis
por: Cserni, Gábor, et al.
Publicado: (2021)

Identification of Cancer-Associated Fibroblast Subtype of Triple-Negative Breast Cancer
por: Wang, Maoli, et al.
Publicado: (2022)

The Roles of DNA Demethylases in Triple-Negative Breast Cancer
por: Panjarian, Shoghag, et al.
Publicado: (2021)

Triple negative breast cancer subtypes and pathologic complete response rate to neoadjuvant chemotherapy
por: Santonja, Angela, et al.
Publicado: (2018)

Tumor suppressor RARRES1- A novel regulator of fatty acid metabolism in epithelial cells
por: Maimouni, Sara, et al.
Publicado: (2018)

Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancer
por: Liu, Yi-Rong, et al.
Publicado: (2016)

Is the future of personalized therapy in triple-negative breast cancer based on molecular subtype?
por: Le Du, Fanny, et al.
Publicado: (2015)

Molecular subtypes of triple-negative breast cancer in women of different race and ethnicity
por: Ding, Yuan Chun, et al.
Publicado: (2019)

Notch Signaling Activation as a Hallmark for Triple-Negative Breast Cancer Subtype
por: Giuli, M. V., et al.
Publicado: (2019)

Identification of three subtypes of triple-negative breast cancer with potential therapeutic implications
por: Jézéquel, Pascal, et al.
Publicado: (2019)

Cisplatin-resistant triple-negative breast cancer subtypes: multiple mechanisms of resistance
por: Hill, David P., et al.
Publicado: (2019)

Radiomics in Triple Negative Breast Cancer: New Horizons in an Aggressive Subtype of the Disease
por: Mireștean, Camil Ciprian, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mdur2to05t3h4kj6573839pqco